Back to TB-500
TB-500 Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for TB-500.
Dosing & Reconstitution Guide
In preclinical studies, TB-500 has been administered at 2.0 mg per week (typically divided into two doses), depending on the animal model and tissue target. These regimens are investigational and not authorized for human application..
Standard / Gradual Approach
5mg VialstandardPhaseDoseVolume
Weeks 1–41,250 mcg (1.25 mg)50 units (0.50 mL)
Weeks 5–121,250 mcg (1.25 mg)50 units (0.50 mL)
Standard / Gradual Approach
5mg VialadvancedPhaseDoseVolume
Weeks 1–2250 mcg (0.25 mg)10 units (0.10 mL)
Weeks 3–8500 mcg (0.50 mg)20 units (0.20 mL)
Weeks 9–12250 mcg (0.25 mg)10 units (0.10 mL)
Protocol Summary
Subcutaneous (SQ): every other day (loading); weekly (maintenance) · Dose range 2–3 mg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Loading Phase: 2.5 mg subQ injection every other day for 4–6 weeks. Maintenance Phase: 2 mg subQ injection once weekly.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3300 mcg/unit
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe